Efficacy and Safety of a Nonanimal Stabilized Hyaluronic Acid/Dextranomer in Improving Fecal Incontinence: A Prospective, Single-Arm, Multicenter, Clinical Study With 36-Month Follow-up

Fecal incontinence affects 7% to 12% of the US adult population, causing social, financial, and quality of life burdens. OBJECTIVE: The primary aim of this study was to evaluate the efficacy and safety of nonanimal stabilized hyaluronic acid/dextranomer through 36 months as a condition of postmarket...

Descripción completa

Detalles Bibliográficos
Autores principales: Quiroz, Lieschen H., Galliano, Domingo E., da Silva, Giovanna, Carmichael, Joseph C., Pan, Li-Chen, Bromley, Emilie R., Hinahara, Jordan G., Goss, Thomas F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829037/
https://www.ncbi.nlm.nih.gov/pubmed/35001051
http://dx.doi.org/10.1097/DCR.0000000000002348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829037/
https://www.ncbi.nlm.nih.gov/pubmed/35001051
http://dx.doi.org/10.1097/DCR.0000000000002348

Ejemplares similares